Yusuke Kurihara

Has grant

Associate Professor

Kurume University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Development of a novel treatment strategy for trypanosomatid infections by targeting 14-3-3 proteins

Open Date: 2026-04-01

Close Date: 2029-03-01

Grant: Close

Analysis of the dormancy-induction mechanisms of the nontuberculous mycobacterium Mycobacterium abscessus

Open Date: 2023-04-01

Close Date: 2026-03-01

Grant: Close

Elucidation of Chlamydia pneumoniae infection strategies involving mitochondrial morphology

Open Date: 2019-04-01

Close Date: 2023-03-01

Grant: Close

Identification of mitochondrial fission inhibitors and elucidation of their mechanisms of action

Open Date: 2016-04-01

Close Date: 2019-03-01

Grant: Close

Functional analysis of mitochondrial autophagy-related factors and development of a molecular model of their mechanisms

Open Date: 2013-04-01

Close Date: 2015-03-01

Articles (4)

Year:

2026

Year:

2025

Fatty acid-binding protein 4 (FABP4) is a cytosolic lipid chaperone predominantly expressed in adipocytes. It has been shown that Trypanosoma cruzi targets adipose tissues and resides in adipocytes. However, how T. cruzi manipulates adipocytes to redirect nutrients for its benefit remains unknown. Here, we uncover the role of FABP4 in facilitating T. cruzi infection in murine 3T3-L1 adipocytes. We demonstrate that pharmacological or genetic inhibition of FABP4, carnitine palmitoyltransferase I (CPT-1), or fatty acid oxidation (FAO) abrogates the intracellular growth of T. cruzi in adipocytes. We also found that inhibiting FABP4, CPT-1, or FAO eliminates the infection-induced elevation of mitochondrial and cellular reactive oxygen species (ROS) in adipocytes. Furthermore, T. cruzi infection-induced elevation of ROS in adipocytes increased the cytosolic Fe 2+ , which fueled T. cruzi proliferation. The treatment with antioxidants such as ROS scavenger N-acetyl cysteine (NAC) or mitochondrial ROS inhibitors MitoQ increased the expression level of mRNA for Ferroportin and Ferritin, leading to the decrease in cytosolic Fe 2+ and the intracellular growth inhibition of T. cruzi in adipocytes. The addition of ferrous sulfate reversed the FABP4 inhibitor or antioxidant-induced decrease in adipocyte parasite burden. Our results demonstrate that T. cruzi exploits host FABP4 to facilitate fatty acid oxidation and elevate cellular ROS, increasing the labile iron pool for the intracellular replication of T. cruzi in adipocytes. These results highlight the therapeutic possibility of host FABP4 as a drug target for T. cruzi infection. IMPORTANCE Persistent infection with a protozoan parasite , Trypanosoma cruzi, causes Chagas disease. While it has been appreciated that adipose tissues are one of the sites of persistent infection, the mechanism of how the parasite survives in adipocytes remains to be established. Our study highlights FABP4, a key regulator of metabolic dysfunction and inflammation, as a therapeutic host target controlling T. cruzi infection in adipocytes. We uncover the importance of FABP4 for T. cruzi replication in mouse adipocytes through engagement with lipid droplet degradation and trafficking of liberated free fatty acids to the host cell’s mitochondria, which are utilized for fatty acid oxidation (FAO). T. cruzi infection-induced FAO fuels reactive oxygen species, and the subsequent iron mobilization accelerates parasite replication. These results shed light on the mechanisms of T. cruzi persistent infection in adipocytes, raising the possibility of host FABP4 as a drug target for T. cruzi infection.

Year:

2025

Fatty acid–binding protein 4 (FABP4) is a critical immune-metabolic modulator, mainly expressed in adipocytes and macrophages, secreted from adipocytes in association with lipolysis, and plays essential pathogenic roles in cardiovascular and metabolic diseases. We previously reported Chlamydia pneumoniae infecting murine 3T3-L1 adipocytes and causing lipolysis and FABP4 secretion in vitro. However, it is still unknown whether C. pneumoniae intranasal lung infection targets white adipose tissues (WATs), induces lipolysis, and causes FABP4 secretion in vivo. In this study, we demonstrate that C. pneumoniae lung infection causes robust lipolysis in WAT. Infection-induced WAT lipolysis was diminished in FABP4−/− mice or FABP4 inhibitor–pretreated wild-type mice. Infection by C. pneumoniae in wild-type but not FABP4−/− mice induces the accumulation of TNF-α– and IL-6–producing M1-like adipose tissue macrophages in WAT. Infection-induced WAT pathology is augmented by endoplasmic reticulum (ER) stress/the unfolded protein response (UPR), which is abrogated by treatment with azoramide, a modulator of the UPR. C. pneumoniae lung infection is suggested to target WAT and induce lipolysis and FABP4 secretion in vivo via ER stress/UPR. FABP4 released from infected adipocytes may be taken up by other neighboring intact adipocytes or adipose tissue macrophages. This process can further induce ER stress activation and trigger lipolysis and inflammation, followed by FABP4 secretion, leading to WAT pathology. A better understanding of the role of FABP4 in C. pneumoniae infection–induced WAT pathology will provide the basis for rational intervention measures directed at C. pneumoniae infection and metabolic syndrome, such as atherosclerosis, for which robust epidemiologic evidence exists.

Year:

2023

Collaborators (7)

Jason Papin

Professor

University of Virginia

UNITED STATES
View details

Kenji Hiromatsu

Fukuoka University

JAPAN
View details

Ryo Ozuru

Assistant Professor

Fukuoka University

JAPAN
View details

Fumiko Obata

Associate Professor

Tottori University

JAPAN
View details

MASAKI FUJITA

Professor

Kyushu University Hospital

JAPAN
View details

Satoshi Miyahara

Indiana University School of Medicine

UNITED STATES
View details

Akinori Shimizu

Fukuoka University

JAPAN
View details